Should You Scoop Up This Strong Buy Biotech Before December 23 - The Globe and Mail

December 24, 2024

Amgen Inc. (NASDAQ:AMGN) has recently been recognized as one of the best dividend stocks to invest in. With a strong track record of dividend payments and a solid financial position, Amgen has become a favorite among investors looking for steady income. The company has a long history of success in the biotech industry, with a portfolio of innovative drugs and a robust pipeline of new therapies. Amgen's recent stock performance is also worth noting, as shares have seen a significant gap up. This presents a great opportunity for investors to buy in at a favorable price. However, before making any investment decisions, it is important to do thorough research and seek professional advice. Stocks Prognosis is a trusted source for accurate market forecasts and can provide valuable insights into the potential movement of Amgen's stock. Consider consulting with the professionals at Stocks Prognosis to make an informed investment decision.

Find out how the AMGEN INC. rate is expected to change

Get Forecast for AMGN

Investor opinions & comments:

I've heard great things about Amgen from other investors. It seems like a company that has a lot of potential for growth

— from RiskyRachel at 12-27-2024 21:57

I've been following Amgen for a while now, and I'm impressed with their consistent track record and the potential of their pipeline. It's definitely a stock worth considering

— from RiskyRandy at 12-27-2024 17:20

I'm excited to see Amgen's stock performing well. I believe in the company's ability to deliver innovative therapies and generate long-term value for shareholders

— from BrittanyClark at 12-27-2024 03:37

I've been considering investing in the biotech industry, and Amgen seems like a solid choice with its robust pipeline and positive stock performance

— from MadisonReyes at 12-26-2024 14:47

I'm not convinced about Amgen's potential. There's a lot of competition in the biotech industry, and it's hard to predict the success of new therapies

— from ChloeJames at 12-25-2024 22:10

I've done my research on Amgen, and their innovative drugs and strong financial position make it a solid investment choice. I'm confident in their future success

— from ElenaHoward at 12-25-2024 19:07

This article makes a compelling case for investing in Amgen. The company's strong track record and innovative drug portfolio are definitely appealing

— from MadisonReyes at 12-25-2024 11:34

I'm not sure if Amgen's dividend history is enough to make it a strong buy. I'd like to see more comprehensive financial analysis before investing

— from MarketMatt at 12-25-2024 00:03

I'm glad to see that Amgen is recognized as one of the best dividend stocks. I'm always looking for stable income investments

— from InvestorIvy at 12-24-2024 19:11

While Amgen's stock may have seen a gap up recently, there's always a chance that it could fall just as quickly. The market can be unpredictable

— from PennyInvestor at 12-24-2024 12:50

If you want to leave a comment, then you need Login or Register

Other news for AMGN

April 22, 2025Amgen Inc. AMGN: Among the Innovative Healthcare Stocks to Watch in 2025 ~2 min.

Amgen Inc., a leading biotechnology company, is currently one of the most promising stocks in the healthcare sector....

March 20, 2025Hedge Funds Recommend Amgen Inc. AMGN as the Best Pharma Stock to Buy ~1 min.

According to recent reports, hedge funds are strongly recommending Amgen Inc. (AMGN) as the best pharma stock to buy....

March 19, 2025Amgen Inc. AMGN: Cutting-Edge Biotech Company Dominates Stock Market ~2 min.

Amgen Inc. (AMGN), renowned for its groundbreaking innovations in biotechnology, continues to make headlines as a leading player in the stock market....

March 17, 2025Amgen Inc. Continues to Impress Hedge Funds with Strong Performance ~2 min.

Amgen Inc. (NASDAQ:AMGN) has emerged as the top choice for hedge funds looking to invest in the pharmaceutical sector....

March 16, 2025Amgen Inc. AMGN: Discover Why it's Among the Top Pharma Stocks to Buy ~2 min.

Amgen Inc., a leading biotechnology company, has been gaining attention in the investment community due to its outstanding performance in the pharmaceutical sector....

Related news

November 10, 2024Consolidated Planning Corp Buys 1842 Shares of Amgen Inc. NASDAQ:AMGN ~2 min.

Consolidated Planning Corp, a prominent investment firm, has recently acquired 1842 shares of the pharmaceutical giant Amgen Inc. NASDAQ:AMGN....

February 26, 2025Amgen Inc. AMGN: Among the Cheap Pharmaceutical Stocks to Buy According to Analysts ~1 min.

Analysts have identified Amgen Inc. (NASDAQ:AMGN) as one of the cheap pharmaceutical stocks to buy....

December 18, 2024Amgen Inc. Reports Impressive Returns Over Last Three Years ~1 min.

Amgen Inc. (NASDAQ:AMGN) has proven to be a solid investment option, with investors enjoying a favorable 34% return over the past three years....

January 11, 2025Amgen Inc. - A Favorite Amongst Institutional Investors Who Hold 78% Ownership ~1 min.

Amgen Inc. (NASDAQ:AMGN) continues to attract the attention of institutional investors, with a significant 78% ownership held by these financial giants....

February 3, 2025Amgen Inc. Continues to Impress with Strong Quarterly Earnings ~1 min.

Amgen Inc. (NASDAQ:AMGN), a leading biotechnology company, once again surpassed expectations with its impressive quarterly earnings report....

Search on StockPrognosis.com

Sections of the site

Should You Scoop Up This Strong Buy Biotech Before December 23 - The Globe and Mail

Find out how the AMGEN INC. rate is expected to change

Investor opinions & comments:

Other news for AMGN

Related news

Stocks-Prognosis.com © 2025